Hashimoto’s thyroiditis is an autoimmune disease in which the immune system attacks the thyroid gland, gradually destroying its ability to produce thyroid hormone. It is the most common cause of hypothyroidism in iodine-sufficient countries like the United States, affecting approximately 5 percent of US adults — and a much higher percentage of women, who are 7 to 10 times more likely to develop the disease than men according to the NIDDK. The disease typically progresses slowly over years; many patients have positive antibodies long before TSH rises and treatment becomes necessary.
What’s Happening in the Thyroid
Hashimoto’s, also called chronic lymphocytic thyroiditis, involves T-cell-mediated destruction of thyroid follicular cells along with B-cell production of antibodies against thyroid peroxidase (TPO) and thyroglobulin. The result is a gradual loss of functional thyroid tissue and declining hormone production.
The thyroid may initially enlarge (goiter) due to inflammation and compensatory growth, then atrophy over years. Some patients experience a brief hyperthyroid phase (Hashitoxicosis) early when stored hormone leaks from damaged cells before settling into hypothyroidism.
Symptoms of Hypothyroidism
Symptoms develop gradually and are often attributed to aging, stress, or postpartum changes. Fatigue is nearly universal. Weight gain — typically 5 to 15 pounds rather than dramatic — accompanies slowed metabolism. Cold intolerance, dry skin, hair loss or thinning, brittle nails, constipation, and muscle aches are common.
Cognitive symptoms — brain fog, slowed thinking, difficulty concentrating, depression — affect a substantial proportion of patients. Menstrual irregularities, fertility problems, and miscarriage risk all rise with significant hypothyroidism. Voice may deepen and the face may appear puffy in long-standing untreated disease.
Per the Mayo Clinic, symptoms can persist or fluctuate even with treated TSH in the normal range, particularly in patients on levothyroxine alone — an active area of clinical debate.
Diagnosis
Diagnosis combines symptoms, thyroid function tests, and antibodies. TSH (thyroid-stimulating hormone) is the most sensitive marker — it rises as the thyroid’s output falls. Free T4 falls in overt hypothyroidism but may be normal in subclinical hypothyroidism (elevated TSH, normal free T4).
Anti-TPO antibodies are positive in 90 to 95 percent of Hashimoto’s patients; anti-thyroglobulin antibodies in 60 to 80 percent. Either supports the autoimmune diagnosis when TSH is elevated. Some patients have positive antibodies with normal TSH for years before progressing to overt disease.
Thyroid ultrasound shows characteristic heterogeneous, hypoechoic appearance in established disease. Imaging is not required for diagnosis but is used when goiter, nodules, or asymmetric enlargement raise concern for other conditions.
Treatment with Levothyroxine
Levothyroxine (T4) is the standard treatment and is taken daily for life in most patients. Typical replacement dose is 1.6 mcg per kg of ideal body weight in primary hypothyroidism, with starting doses lower in older patients or those with cardiac disease. The drug should be taken on an empty stomach 30 to 60 minutes before food, and at least 4 hours apart from calcium, iron, antacids, and certain other medications that impair absorption.
TSH is rechecked 6 to 8 weeks after starting or changing dose. Most guidelines target a TSH in the lower half of the normal range (0.5 to 2.5 mIU/L) for symptomatic patients. Generic and brand levothyroxine are bioequivalent but switching brands or generics can produce small dose differences requiring TSH recheck.
The role of T3 (liothyronine) and combination T4/T3 therapy is debated. Most patients do well on levothyroxine alone, but a subset — perhaps 10 to 15 percent — report better symptoms on combination therapy in some randomized trials. Desiccated thyroid extract (Armour, NP Thyroid) is used by some patients and clinicians but is less consistently dosed.
Subclinical Hypothyroidism: When to Treat
Subclinical hypothyroidism — TSH 4.5 to 10 mIU/L with normal free T4 — affects 5 to 10 percent of US adults. Whether to treat is controversial. Most guidelines support treatment when TSH is over 10, when symptoms are present, when antibodies are positive (suggesting progression risk), in pregnancy or planning pregnancy, and in younger patients. Older asymptomatic patients with mildly elevated TSH may not benefit from treatment per PMC reviews.
About 5 percent of subclinical hypothyroid patients per year progress to overt disease, with higher rates in those with positive TPO antibodies.
Pregnancy Considerations
Untreated hypothyroidism during pregnancy raises risks of miscarriage, preeclampsia, preterm birth, low birth weight, and neurodevelopmental problems in the child. TSH targets are tighter during pregnancy — typically below 2.5 mIU/L in the first trimester. Levothyroxine doses usually need to increase 25 to 50 percent during pregnancy, with TSH checked every 4 to 6 weeks.
Postpartum thyroiditis — distinct from Hashimoto’s but with overlapping pathology — affects roughly 5 to 10 percent of women in the first year after delivery, often presenting with hyperthyroid then hypothyroid phases. Most patients recover, but a meaningful subset develops permanent hypothyroidism.
Lifestyle Factors
Iodine intake matters. Severe iodine deficiency can cause hypothyroidism, but in iodine-sufficient countries excess iodine (kelp supplements, certain medications, contrast dye) can worsen autoimmune thyroiditis. Most patients should aim for adequate but not excessive iodine — the US RDA is 150 mcg/day, with typical American diets meeting this.
Selenium has shown modest reductions in TPO antibody levels in some trials, but evidence for clinical benefit is mixed. Adequate selenium from diet (Brazil nuts, fish, eggs) is reasonable; high-dose supplementation is not generally recommended.
The “Hashimoto’s diet” — gluten-free, anti-inflammatory, sometimes autoimmune protocol — has limited rigorous evidence outside of patients with concomitant celiac disease, which is more common in Hashimoto’s than the general population. Mediterranean-style eating, weight management, and regular exercise are reasonable for general health.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience extreme lethargy or unresponsiveness with cold body temperature (possible myxedema coma — rare but life-threatening), severe shortness of breath, very slow heart rate with weakness, or sudden severe neck swelling or pain. Myxedema coma occurs in severe untreated hypothyroidism, especially in older patients during illness or surgery, and has substantial mortality if not promptly recognized.
Associated Autoimmune Conditions
Hashimoto’s commonly clusters with other autoimmune diseases — type 1 diabetes, celiac disease, vitiligo, pernicious anemia, Addison’s disease, and rheumatoid arthritis. Patients with autoimmune polyglandular syndromes need broader monitoring. Our Graves’ disease guide covers the other major autoimmune thyroid disease, which can occur in the same families and occasionally even in the same patient over time.
Lymphoma of the thyroid is rare but occurs at higher rates in Hashimoto’s patients than the general population. Sudden thyroid enlargement, hoarseness, or compressive symptoms warrant evaluation.
When to See a Doctor
Persistent fatigue, weight changes, cold intolerance, or other hypothyroid symptoms warrant TSH testing. So does a family history of thyroid disease in someone planning pregnancy. Established Hashimoto’s patients typically have TSH checked every 6 to 12 months when stable and 6 to 8 weeks after dose changes.
Many doctors recommend endocrinology referral for difficult-to-control hypothyroidism, persistent symptoms despite normal TSH, pregnancy with thyroid disease, or unusual nodules or rapid thyroid enlargement. Our medical conditions overview covers chronic disease management more broadly.
Frequently Asked Questions
Can Hashimoto’s be cured?
Hashimoto’s is a chronic autoimmune disease without a cure, but it is highly manageable with levothyroxine replacement. Most patients live entirely normal lives with daily medication and periodic TSH monitoring. The autoimmune process typically continues, gradually destroying remaining thyroid tissue.
Will I gain weight with Hashimoto’s?
Untreated hypothyroidism typically causes 5 to 15 pounds of weight gain, mostly fluid and modest fat. With proper levothyroxine treatment, metabolism normalizes and significant ongoing weight gain is uncommon. Weight management challenges in treated patients are similar to those of the general population, though some patients struggle with persistent symptoms.
Does Hashimoto’s cause hair loss?
Yes. Diffuse hair thinning, eyebrow loss (especially the lateral third), and dry brittle hair are characteristic of hypothyroidism. Hair regrowth typically follows TSH normalization, though the process can take 6 to 12 months. Other causes of hair loss — iron deficiency, low ferritin, vitamin D deficiency — should also be checked.
Can stress cause Hashimoto’s?
Stress does not directly cause Hashimoto’s, but significant emotional or physical stress may trigger or worsen autoimmune disease in genetically predisposed individuals. Postpartum stress is a known trigger period. Managing stress is reasonable for general health but is not a substitute for thyroid hormone replacement when needed.
The Bottom Line
Hashimoto’s thyroiditis is one of the most common autoimmune diseases in the United States and one of the most straightforward to treat. Daily levothyroxine, regular TSH monitoring, and attention to absorption with timing and other medications produce excellent outcomes for most patients. Awareness of the condition during pregnancy, careful management of subclinical disease, and screening for associated autoimmune conditions all improve long-term care. Patients who understand their disease, take their medication consistently on an empty stomach, and partner with primary care or endocrinology for ongoing monitoring generally do well — though some continue to experience persistent symptoms that warrant deeper investigation and individualized care.